On January 29, 2025, Portage Biotech Inc. sold 524,390 ordinary shares for $2.15 million, priced at $4.10 per share, to directors for corporate purposes. This event is significant and is categorized under Changes in capital structure.
AI Assistant
ALPHA COMPUTE CORP
2025
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.